{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:41:46Z","timestamp":1789429306865,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1208\/s12249-019-1484-y","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T16:03:02Z","timestamp":1565712182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery"],"prefix":"10.1208","volume":"20","author":[{"given":"Maryam","family":"khatoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Farhan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Shahnaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiza","family":"ur Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Fakhar-ud-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"ur Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul Majid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kifayat Ullah","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"issue":"5","key":"1484_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1192\/bjp.184.5.386","volume":"184","author":"TB \u00dcst\u00fcn","year":"2004","unstructured":"\u00dcst\u00fcn TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray C. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184(5):386\u201392.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"1484_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/jama.287.2.203","volume":"287","author":"M Olfson","year":"2002","unstructured":"Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. Jama. 2002;287(2):203\u20139.","journal-title":"Jama."},{"issue":"3\u20134","key":"1484_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","volume":"41","author":"CB Nemeroff","year":"2007","unstructured":"Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res. 2007;41(3\u20134):189\u2013206.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"1484_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.euroneuro.2004.01.002","volume":"14","author":"MJ Detke","year":"2004","unstructured":"Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo-and paroxetine-controlled trial. Eur Neuropsychopharmacol. 2004;14(6):457\u201370.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"1484_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1124\/dmd.31.9.1142","volume":"31","author":"R Lantz","year":"2003","unstructured":"Lantz R, Gillespie T, Rash T, Kuo F, Skinner M, Kuan H, et al. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Metab Dispos. 2003;31(9):1142\u201350.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1484_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2306\/scienceasia1513-1874.2010.36.305","volume":"36","author":"MI Alam","year":"2010","unstructured":"Alam MI, Baboota S, Kohli K, Ali J, Ahuja A. Pharmacodynamic evaluation of proniosomal transdermal therapeutic gel containing celecoxib. ScienceAsia. 2010;36(4):305\u201311.","journal-title":"ScienceAsia"},{"key":"1484_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6847971","volume":"2018","author":"M Gharbavi","year":"2018","unstructured":"Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. 2018;2018:1\u201315.","journal-title":"Adv Pharmacol Sci"},{"issue":"4","key":"1484_CR8","first-page":"189","volume":"2","author":"K Yadav","year":"2010","unstructured":"Yadav K, Yadav D, Saroha K, Nanda S, Mathur P, Syan N. Proniosomal gel: a provesicular approach for transdermal drug delivery. Pharm Lett. 2010;2(4):189\u201398.","journal-title":"Pharm Lett"},{"key":"1484_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.nantod.2017.06.008","volume":"15","author":"S Hassan","year":"2017","unstructured":"Hassan S, Prakash G, Ozturk AB, Saghazadeh S, Sohail MF, Seo J, et al. Evolution and clinical translation of drug delivery nanomaterials. Nano Today. 2017;15:91\u2013106.","journal-title":"Nano Today"},{"issue":"4","key":"1484_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/10717544.2013.841783","volume":"21","author":"VR Yasam","year":"2014","unstructured":"Yasam VR, Jakki SL, Natarajan J, Kuppusamy G. A review on novel vesicular drug delivery: proniosomes. Drug Deliv. 2014;21(4):243\u20139.","journal-title":"Drug Deliv"},{"issue":"3","key":"1484_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","volume":"152","author":"R Thorne","year":"2008","unstructured":"Thorne R, Hanson L, Ross T, Tung D, Frey IW. Delivery of interferon-\u03b2 to the monkey nervous system following intranasal administration. Neuroscience. 2008;152(3):785\u201397.","journal-title":"Neuroscience."},{"issue":"5","key":"1484_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","volume":"40","author":"MI Alam","year":"2010","unstructured":"Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, et al. Strategy for effective brain drug delivery. Eur J Pharm Sci. 2010;40(5):385\u2013403.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1484_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","volume":"10","author":"F Sonvico","year":"2018","unstructured":"Sonvico F, Clementino A, Buttini F, Colombo G, Pescina S, Stanis\u00e7uaski Guterres S, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics. 2018;10(1):34.","journal-title":"Pharmaceutics."},{"issue":"2","key":"1484_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1208\/s12249-019-1297-z","volume":"20","author":"M Sajjad","year":"2019","unstructured":"Sajjad M, Khan MI, Naveed S, Ijaz S, Qureshi OS, Raza SA, et al. Folate-functionalized thiomeric nanoparticles for enhanced docetaxel cytotoxicity and improved oral bioavailability. AAPS PharmSciTech. 2019;20(2):81.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"1484_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/nnm-2018-0038","volume":"14","author":"Iqra Afzal","year":"2019","unstructured":"Afzal I, Sarwar HS, Sohail MF, Varikuti S, Jahan S, Akhtar S, Yasinzai M, Satoskar AR, Shahnaz G Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. Nanomedicine. 2019;(0), 14, 387, 406.","journal-title":"Nanomedicine"},{"issue":"37","key":"1484_CR16","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1039\/C6TB01348A","volume":"4","author":"MF Sohail","year":"2016","unstructured":"Sohail MF, Javed I, Hussain SZ, Sarwar S, Akhtar S, Nadhman A, et al. Folate grafted thiolated chitosan enveloped nanoliposomes with enhanced oral bioavailability and anticancer activity of docetaxel. J Mater Chem B. 2016;4(37):6240\u20138.","journal-title":"J Mater Chem B"},{"issue":"2","key":"1484_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10837450701831211","volume":"13","author":"A Azeem","year":"2008","unstructured":"Azeem A, Jain N, Iqbal Z, Ahmad FJ, Aqil M, Talegaonkar S. Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation. Pharm Dev Technol. 2008;13(2):155\u201363.","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"1484_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/08982104.2016.1167737","volume":"27","author":"RM Khalil","year":"2017","unstructured":"Khalil RM, Abdelbary GA, Basha M, Awad GE, El-Hashemy HA. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl. J Liposome Res. 2017;27(2):118\u201329.","journal-title":"J Liposome Res"},{"key":"1484_CR19","doi-asserted-by":"crossref","unstructured":"Sarwar HS, Sohail MF, Saljoughian N, Rehman AU, Akhtar S, Nadhman A, et al. Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis. Artif Cell Nanomed Biotechnol. 2018:1\u201311.","DOI":"10.1080\/21691401.2018.1430699"},{"key":"1484_CR20","doi-asserted-by":"crossref","unstructured":"Mehta M, Garg M. Development and optimization of boswellic acids loaded proniosomal gel. Planta Med. 2016;82(S 01):P1033.","DOI":"10.1055\/s-0036-1597013"},{"issue":"1","key":"1484_CR21","doi-asserted-by":"publisher","first-page":"13304","DOI":"10.1038\/s41598-018-30749-3","volume":"8","author":"MF Sohail","year":"2018","unstructured":"Sohail MF, Hussain SZ, Saeed H, Javed I, Sarwar HS, Nadhman A, et al. Polymeric nanocapsules embedded with ultra-small silver nanoclusters for synergistic pharmacology and improved oral delivery of docetaxel. Sci Rep. 2018;8(1):13304.","journal-title":"Sci Rep"},{"issue":"1","key":"1484_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jconrel.2010.01.033","volume":"144","author":"G Shahnaz","year":"2010","unstructured":"Shahnaz G, Perera G, Sakloetsakun D, Rahmat D, Bernkop-Schn\u00fcrch A. Synthesis, characterization, mucoadhesion and biocompatibility of thiolated carboxymethyl dextran\u2013cysteine conjugate. J Control Release. 2010;144(1):32\u20138.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"1484_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijpharm.2012.02.044","volume":"428","author":"G Shahnaz","year":"2012","unstructured":"Shahnaz G, Vetter A, Barthelmes J, Rahmat D, Laffleur F, Iqbal J, et al. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm. 2012;428(1\u20132):164\u201370.","journal-title":"Int J Pharm"},{"issue":"2","key":"1484_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1208\/s12249-013-9956-y","volume":"14","author":"RM Farid","year":"2013","unstructured":"Farid RM, Etman MA, Nada AH, Abd El Azeem RE. Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts. AAPS Pharm Sci Tech. 2013;14(2):712\u20138.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"6","key":"1484_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3109\/10717544.2014.896428","volume":"22","author":"SA Rahman","year":"2015","unstructured":"Rahman SA, Abdelmalak NS, Badawi A, Elbayoumy T, Sabry N, Ramly AE. Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study. Drug Deliv. 2015;22(6):731\u20139.","journal-title":"Drug Deliv"},{"issue":"8","key":"1484_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/03639040600814676","volume":"32","author":"M Joshi","year":"2006","unstructured":"Joshi M, Patravale V. Formulation and evaluation of nanostructured lipid carrier (NLC)\u2013based gel of Valdecoxib. Drug Dev Ind Pharm. 2006;32(8):911\u20138.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"1484_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/nnm.13.26","volume":"9","author":"F Laffleur","year":"2014","unstructured":"Laffleur F, Hintzen F, Shahnaz G, Rahmat D, Leithner K, Bernkop-Schn\u00fcrch A. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus. Nanomedicine. 2014;9(3):387\u201396.","journal-title":"Nanomedicine."},{"issue":"1","key":"1484_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejpb.2011.09.010","volume":"80","author":"J Iqbal","year":"2012","unstructured":"Iqbal J, Shahnaz G, Perera G, Hintzen F, Sarti F, Bernkop-Schn\u00fcrch A. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide. Eur J Pharm Biopharm. 2012;80(1):95\u2013102.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1484_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-5173(99)00442-1","volume":"198","author":"N Washington","year":"2000","unstructured":"Washington N, Steele R, Jackson S, Bush D, Mason J, Gill D, et al. Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm. 2000;198(2):139\u201346.","journal-title":"Int J Pharm"},{"issue":"1","key":"1484_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2217\/nnm-2017-0255","volume":"13","author":"HS Sarwar","year":"2018","unstructured":"Sarwar HS, Ashraf S, Akhtar S, Sohail MF, Hussain SZ, Rafay M, et al. Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis. Nanomedicine. 2018;13(1):25\u201341.","journal-title":"Nanomedicine."},{"issue":"7","key":"1484_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4314\/tjpr.v13i7.4","volume":"13","author":"MF Sohail","year":"2014","unstructured":"Sohail MF, Shah PA, Tariq I, Saeed-ul-Hassan S, Amin U, Raza SA, et al. Development and in vitro evaluation of flurbiprofen microcapsules prepared by modified solvent evaporation technique. Trop J Pharm Res. 2014;13(7):1031\u20138.","journal-title":"Trop J Pharm Res"},{"issue":"2","key":"1484_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejpb.2012.10.008","volume":"83","author":"D Rahmat","year":"2013","unstructured":"Rahmat D, M\u00fcller C, Barthelmes J, Shahnaz G, Martien R, Bernkop-Schn\u00fcrch A. Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles. Eur J Pharm Biopharm. 2013;83(2):149\u201355.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1484_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0939-6411(01)00158-8","volume":"52","author":"E Larrucea","year":"2001","unstructured":"Larrucea E, Arellano A, Santoyo S, Ygartua P. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur J Pharm Biopharm. 2001;52(2):113\u20139.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1484_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1208\/s12249-008-9121-1","volume":"9","author":"VB Junyaprasert","year":"2008","unstructured":"Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech. 2008;9(3):851\u20139.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1484_CR35","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1208\/s12249-008-9126-9","volume":"9","author":"HA Gad","year":"2008","unstructured":"Gad HA, El-Nabarawi MA, El-Hady SSA. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and\/or doxycycline for treatment of periodontitis. AAPS PharmSciTech. 2008;9(3):878\u201384.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1484_CR36","first-page":"217","volume":"67","author":"S Dash","year":"2010","unstructured":"Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217\u201323.","journal-title":"Acta Pol Pharm"},{"issue":"14","key":"1484_CR37","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2174\/138161210791164108","volume":"16","author":"J Ali","year":"2010","unstructured":"Ali J, Ali M, Baboota S, Kaur Sahni J, Ramassamy C, Dao L. Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des. 2010;16(14):1644\u201353.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1484_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/15701638113109990031","volume":"10","author":"N Ravouru","year":"2013","unstructured":"Ravouru N, Kondreddy P, Korakanchi D. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting. Curr Drug Disc Technol. 2013;10(4):270\u201382.","journal-title":"Curr Drug Disc Technol"},{"key":"1484_CR39","first-page":"31","volume":"64","author":"CD Kilts","year":"2003","unstructured":"Kilts CD. Potential new drug delivery systems for antidepressants: an overview. J Clin Psychiat. 2003;64:31\u20133.","journal-title":"J Clin Psychiat"},{"issue":"2","key":"1484_CR40","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003;6(2):252\u201373.","journal-title":"J Pharm Pharm Sci"},{"issue":"3","key":"1484_CR41","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1208\/s12249-008-9114-0","volume":"9","author":"MMA Ibrahim","year":"2008","unstructured":"Ibrahim MMA, Sammour OA, Hammad MA, Megrab NA. In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS Pharm Sci Tech. 2008;9(3):782\u201390.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"1\u20132","key":"1484_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.04.020","volume":"377","author":"P Balakrishnan","year":"2009","unstructured":"Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm. 2009;377(1\u20132):1\u20138.","journal-title":"Int J Pharm"},{"issue":"3","key":"1484_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3797\/scipharm.1201-03","volume":"80","author":"L Thomas","year":"2012","unstructured":"Thomas L, Viswanad V. Formulation and optimization of clotrimazole-loaded proniosomal gel using 32 factorial design. Sci Pharm. 2012;80(3):731\u201348.","journal-title":"Sci Pharm"},{"issue":"1\u20132","key":"1484_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0378-5173(02)00301-0","volume":"244","author":"Y Hao","year":"2002","unstructured":"Hao Y, Zhao F, Li N, Yang Y. Li Ka. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002;244(1\u20132):73\u201380.","journal-title":"Int J Pharm"},{"key":"1484_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.22159\/ijpps.2017v9i2.13793","volume":"9","author":"H Peddapalli","year":"2017","unstructured":"Peddapalli H, Chinnala KM, Banala N. Design and in vitro characterization of mucoadhesive buccal patches of duloxetine hydrochloride. Int J Pharm Pharm Sci. 2017;9:52\u20139.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"4","key":"1484_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0973-8398.76752","volume":"4","author":"EbtessamA Essa","year":"2010","unstructured":"Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm. 2014;4(4).","journal-title":"Asian Journal of Pharmaceutics"},{"issue":"4","key":"1484_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/1061186X.2018.1512112","volume":"27","author":"S Naskar","year":"2019","unstructured":"Naskar S, Koutsu K, Sharma S. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research. J Drug Target. 2019;27(4):379\u201393.","journal-title":"J Drug Target"},{"issue":"1","key":"1484_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0939-6411(03)00157-7","volume":"57","author":"M Roldo","year":"2004","unstructured":"Roldo M, Hornof M, Caliceti P, Bernkop-Schn\u00fcrch A. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur J Pharm Biopharm. 2004;57(1):115\u201321.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"1484_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40005-017-0320-1","volume":"47","author":"G-H Son","year":"2017","unstructured":"Son G-H, Lee B-J, Cho C-W. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. J Pharml Investig. 2017;47(4):287\u201396.","journal-title":"J Pharml Investig"},{"issue":"4","key":"1484_CR50","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","volume":"116","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602\u201363.","journal-title":"Chem Rev"},{"issue":"1","key":"1484_CR51","first-page":"77","volume":"2","author":"G Singhvi","year":"2011","unstructured":"Singhvi G, Singh M. In-vitro drug release characterization models. Int J Pharm Stud Res. 2011;2(1):77\u201384.","journal-title":"Int J Pharm Stud Res"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1484-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T23:05:45Z","timestamp":1597187145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1484-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1484-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"288"}}